Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG Vaccine in Radiologically Isolated Syndrome
NCT03888924Phase 2Recruiting
- Sponsor
- Sant'Andrea Hospital
- Start
- Jun 2019
- Primary completion
- Jul 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bcg vaccine in multiple sclerosis (MS) (2 arms), sponsored by Sant'Andrea Hospital. Primary endpoint: cumulative number of Combined Unique Active Lesions at 12 months. Started Jun 2019; status: recruiting.
02
Drugs
bcg vaccine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT03888924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03888924.